ADMA - ADMA Biologics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ADMA is currently covered by 4 analysts with an average price target of $21.88. This is a potential upside of $3.91 (21.76%) from yesterday's end of day stock price of $17.97.

ADMA Biologics's activity chart (see below) currently has 25 price targets and 52 ratings on display. The stock rating distribution of ADMA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 84.76% with an average time for these price targets to be met of 842.71 days.

Highest price target for ADMA is $26, Lowest price target is $14, average price target is $21.88.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 08-Nov-2024. First documented stock forecast 09-Sep-2015.

Currently out of the existing stock ratings of ADMA, 25 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$26

$8.7 (50.29%)

$18

1 months 25 days ago
(08-Nov-2024)

14/15 (93.33%)

$3.04 (13.24%)

298

Buy

$20

$2.7 (15.61%)

$20

3 months 13 days ago
(20-Sep-2024)

8/8 (100%)

$0.02 (0.10%)

139

Buy

$14

$-3.3 (-19.08%)

$12

6 months 13 days ago
(20-Jun-2024)

8/8 (100%)

$3.29 (30.72%)

520

Buy

$6

$-11.3 (-65.32%)

1 years 4 months 23 days ago
(10-Aug-2023)

4/4 (100%)

$1.69 (39.21%)

784

Buy

$4

$-13.3 (-76.88%)

$7

4 years 1 months 27 days ago
(06-Nov-2020)

6/6 (100%)

$2.09 (109.42%)

1736

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ADMA (ADMA Biologics) average time for price targets to be met?

On average it took 842.71 days on average for the stock forecasts to be realized with a an average price target met ratio 84.76

Which analyst has the current highest performing score on ADMA (ADMA Biologics) with a proven track record?

JASON KOLBERT

Which analyst has the current lower performing score on ADMA (ADMA Biologics) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on ADMA (ADMA Biologics)?

Jason Kolbert has 5 price targets and 7 ratings on ADMA

Which analyst is the currently most bullish on ADMA (ADMA Biologics)?

Raghuram Selvaraju with highest potential upside - $8.7

Which analyst is the currently most reserved on ADMA (ADMA Biologics)?

Leland Gershell with lowest potential downside - -$13.3

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?